Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Jan;2(1):61-9.
doi: 10.1007/s11910-002-0055-9.

Periodic paralysis: understanding channelopathies

Affiliations
Review

Periodic paralysis: understanding channelopathies

Frank Lehmann-Horn et al. Curr Neurol Neurosci Rep. 2002 Jan.

Abstract

Familial periodic paralyses are typical channelopathies (i.e., caused by functional disturbances of ion channel proteins). The episodes of flaccid muscle weakness observed in these disorders are due to underexcitability of sarcolemma leading to a silent electromyogram and the lack of action potentials even upon electrical stimulation. Interictally, ion channel malfunction is well compensated, so that special exogenous or endogenous triggers are required to produce symptoms in the patients. An especially obvious trigger is the level of serum potassium (K+), the ion responsible for resting membrane potential and degree of excitability. The clinical symptoms can be caused by mutations in genes coding for ion channels that mediate different functions for maintaining the resting potential or propagating the action potential, the basis of excitability. The phenotype is determined by the type of functional defect brought about by the mutations, rather than the channel effected, because the contrary phenotypes hyperkalemic periodic paralysis (HyperPP) and hypokalemic periodic paralysis (HypoPP) may be caused by point mutations in the same gene. Still, the common mechanism for inexcitability in all known episodic-weakness phenotypes is a long-lasting depolarization that inactivates sodium ion (Na+) channels, initiating the action potential.

PubMed Disclaimer

References

    1. Muscle Nerve. 1987 May;10(4):363-74 - PubMed
    1. Neurology. 1999 Dec 10;53(9):1932-6 - PubMed
    1. Neurology. 2000 Jun 13;54(11):2190-2 - PubMed
    1. Nature. 1989 Jun 22;339(6226):597-603 - PubMed
    1. J Physiol. 2000 Sep 1;527 Pt 2:325-32 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources